Delivery Order SPE2DB20D7061-SPE2DB25FSPB3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,548.17 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, a broad-spectrum antibiotic used in military and federal healthcare settings. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement practices. The award was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and the product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,978.19 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ceftriaxone is a third-generation cephalosporin antibiotic commonly used throughout military and federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a broad-spectrum antibiotic commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $5,353.10, is scheduled for completion by August 14, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $9,224.08 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare systems. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance will be completed by August 13, 2025, with the product supplied from AmerisourceBergen's location in Conshohocken,...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ceftriaxone 2 GM-D5W bags, a common antibiotic medication used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $2,890.58, represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ceftriaxone 1 GM-D5W bags with a ceiling value of $3,436.68. This firm fixed-price delivery order, which is expected to be completed by August 6, 2025, represents a competitively awarded, non-set-aside contract and will be performed at the contractor's Conshohocken facility. Ceftriaxone...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,142.63 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, an antibiotic medication commonly used in military and federal healthcare settings. This firm fixed-price delivery order, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $1,352.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of August 20, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and performance...
- The Defense Logistics Agency awarded a delivery order valued at $7,277.41 to AmerisourceBergen Drug Corp for Ceftriaxone 2 GM-D5W bags, a critical antibiotic medication used in military and federal healthcare systems. This firm fixed-price delivery order, awarded on August 18, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.62 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, with an ultimate completion date of July 31, 2025. This award was made on a firm fixed price basis with no set-aside designation, indicating competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPB3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,298.59 to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 2 GM-D5W bags, a third-generation cephalosporin antibiotic used for treating serious bacterial infections across military and federal healthcare systems. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, was executed on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle valued through December 2026 that provides comprehensive global pharmaceutical support to the Department of Defense and affiliated healthcare systems. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills competitively awarded delivery orders for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's extensive federal portfolio demonstrates its capability to meet DLA's medical supply chain requirements for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 8/1/25 |